Deals
|
 |
| This
announcement appears as a matter of record only
|
|
Milkhaus Laboratories
Received $5,000,000
for Phase 2 clinical trials from
Current
Shareholders
FOCUS Regional
Managing Partner William S. Lear assisted in the
negotiations as the representative of Milkhaus
Laboratories.
|
| |
|
|
|
 |
 |
Complimentary,
middle market monthly email newsletter. Relevant insights, trends, and news. Substance, not fluff.
more information....
|
|
 |
| Read more about FOCUS Enterprises'
various business sector experience...
Read More |
|
|
